Leaderboards/Dermatology and Skin Diseases

Dermatology and Skin Diseases

Last updated July 15, 2026

Rising Stars

Fresh ink, massive impact

Researchers

1
Xiaoxuan Zhang
Hainan University
2
Antony Raharja
Whipps Cross University Hospital
3
Yue Zheng
Guangxi University
4
Sara Saheb Kashaf
National Institutes of Health
5
Javier Aguilera‐Lizarraga
University of Cambridge
6
Duohang Bi
Medical Protective
7
Tanvi Karve
Mercer University
8
Cristiana Oliveira
University of Minho
9
Izabella Ryguła
Medical University of Silesia
10
Samia Almoughrabie
University of California San Diego

Papers

1
Microneedles’ Device: Design, Fabrication, and Applications
Macromol—A Journal of Macromolecular Research|2024
107 cit.
2
Publication in Advanced Drug Delivery Reviews (2024) [89 citations, W4396520892]
Advanced Drug Delivery Reviews|2024
89 cit.
3
Impact of Diet and Nutrition in Patients with Acne Vulgaris
Nutrients|2024
49 cit.
4
The Role of the Gut Microbiome and Microbial Dysbiosis in Common Skin Diseases
International Journal of Molecular Sciences|2024
39 cit.
5
Psychological Stress-Induced Local Immune Response to Food Antigens Increases Pain Signaling Across the Gut in Mice
Gastroenterology|2025
11 cit.
6
Publication in International Journal of Pharmaceutics (2024) [9 citations, W4392660694]
International Journal of Pharmaceutics|2024
9 cit.
7
Intestinal barrier function in the naked mole-rat: an emergent model for gastrointestinal insights
American Journal of Physiology-Gastrointestinal and Liver Physiology|2024
9 cit.
8
Recent advances in cascade isothermal nucleic acid amplification technologies beyond single-step amplification
Microchemical Journal|2025
7 cit.
9
Controllable Histotomy Based on Hierarchical Magnetic Microneedle Array Robots
Engineering|2024
5 cit.
10
Pro-inflammatory mediators sensitise transient receptor potential melastatin 3 cation channel (TRPM3) function in mouse sensory neurons
Neuropharmacology|2025
4 cit.

Emerging Leaders

Drafting the new consensus

Researchers

1
Brad Shumel
Regeneron (United States)
2
Ben Boursi
Tel Aviv University
3
Ashish Bansal
Regeneron (United States)
4
Ricardo Rojo
Pfizer (United States)
5
Alexandria P. Cogdill
University of Pennsylvania
6
Marie Vétizou
Innate Pharma (France)
7
Vancheswaran Gopalakrishnan
AstraZeneca (United States)
8
Zelma C. Chiesa Fuxench
University of Pennsylvania
9
Vidhya Hariharan
American Academy of Dermatology
10
José V. Moyano
University of Chicago

Papers

1
Long-Term Efficacy and Safety of Dupilumab in Adolescents with Moderate-to-Severe Atopic Dermatitis: Results Through Week 52 from a Phase III Open-Label Extension Trial (LIBERTY AD PED-OLE)
American Journal of Clinical Dermatology|2022
120 cit.
2
Dupilumab treatment improves signs, symptoms, quality of life, and work productivity in patients with atopic hand and foot dermatitis: Results from a phase 3, randomized, double-blind, placebo-controlled trial
Journal of the American Academy of Dermatology|2024
47 cit.
3
Dupilumab Safety and Efficacy up to 1 Year in Children Aged 6 Months to 5 Years with Atopic Dermatitis: Results from a Phase 3 Open-Label Extension Study
American Journal of Clinical Dermatology|2024
46 cit.
4
Risk of Inflammatory Bowel Disease in Patients With Atopic Dermatitis
JAMA Dermatology|2023
28 cit.
5
A case series of live attenuated vaccine administration in dupilumab‐treated children with atopic dermatitis
Pediatric Dermatology|2024
21 cit.
6
Duration of immunotherapy in dMMR/MSI-H metastatic colorectal cancer patients
European Journal of Cancer|2024
20 cit.
7
<i>In utero</i> or early-in-life exposure to antibiotics and the risk of childhood atopic dermatitis, a population-based cohort study
British Journal of Dermatology|2023
18 cit.
8
Association between atopic dermatitis, autoimmune illnesses, Epstein-Barr virus, and cytomegalovirus
Archives of Dermatological Research|2023
10 cit.
9
Risk of atopic dermatitis and the atopic march paradigm in children of mothers with atopic illnesses: A birth cohort study from the United Kingdom
Journal of the American Academy of Dermatology|2023
10 cit.
10
Immunotherapy in mismatch repair-deficient metastatic colorectal cancer – Outcome and novel predictive markers
European Journal of Cancer|2023
8 cit.

Current Senior Leaders

Wrote the book, still writing it

Researchers

1
Donald Y.M. Leung
Boston Children's Hospital
2
Emma Guttman‐Yassky
Icahn School of Medicine at Mount Sinai
3
Mark R. Prausnitz
Georgia Institute of Technology
4
Julia A. Segre
National Human Genome Research Institute
5
Peter M. Elias
University of California, San Francisco
6
Richard L. Gallo
University of California San Diego
7
James G. Krueger
Rockefeller University
8
Joke A. Bouwstra
Centre for Human Drug Research
9
Ryan F. Donnelly
Queen's University Belfast
10
Johannes Ring
Technical University of Munich

Papers

1
Topographical and Temporal Diversity of the Human Skin Microbiome
Science|2009
3k cit.
2
Endogenous Antimicrobial Peptides and Skin Infections in Atopic Dermatitis
New England Journal of Medicine|2002
2k cit.
3
Temporal shifts in the skin microbiome associated with disease flares and treatment in children with atopic dermatitis
Genome Research|2012
1.8k cit.
4
Microfabricated Microneedles: A Novel Approach to Transdermal Drug Delivery
Journal of Pharmaceutical Sciences|1998
1.3k cit.
5
INCIDENCE AND SEVERITY OF ANAPHYLACTOID REACTIONS TO COLLOID VOLUME SUBSTITUTES
The Lancet|1977
1.3k cit.
6
Topographic diversity of fungal and bacterial communities in human skin
Nature|2013
1.2k cit.
7
Innate antimicrobial peptide protects the skin from invasive bacterial infection
Nature|2001
1.2k cit.
8
Biogeography and individuality shape function in the human skin metagenome
Nature|2014
1.2k cit.
9
Consensus‐based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part I
Journal of the European Academy of Dermatology and Venereology|2018
1.2k cit.
10
Cytokine modulation of atopic dermatitis filaggrin skin expression
Journal of Allergy and Clinical Immunology|2007
1.1k cit.

Reagents for Dermatology and Skin Diseases

Citation-validated products used in this field

🔥 Trending

Gaining adoption fast

⭐ Top Rated

Best all-around

Acris Antibodies

Mouse Anti-CD154 / CD40L Monoclonal Antibody, Unconjugated Clone 2A3

Cited in 8 papers
#4CD40-2A3
View Evidence →
Cell Signaling TechnologyEvidence 65

Phospho-p90RSK (Ser380) (D5D8) Rabbit Monoclonal Antibody (Alexa Fluor® 647 Conjugate)

Cited in 7 papers
#13575$493
View Evidence →
Cell Signaling TechnologyEvidence 66

CD14 (D7A2T) Rabbit Monoclonal Antibody (Alexa Fluor® 647 Conjugate)

Cited in 7 papers
#33676$465
View Evidence →

🌟 All-Time

Most validated

Cell Signaling TechnologyEvidence 66

Toll-like Receptor 9 (D2C9) Rabbit Monoclonal Antibody

Cited in 11 papers
#5845$152,351
View Evidence →
Cell Signaling TechnologyEvidence 66

Phospho-Stat1 (Tyr701) (58D6) Rabbit Monoclonal Antibody (Alexa Fluor® 555 Conjugate)

Cited in 10 papers
#8183$493
View Evidence →
Acris AntibodiesEvidence 60

Mouse Anti-Canine Distemper Virus Monoclonal Antibody, Unconjugated, Clone 39937

Cited in 8 papers
#3CD10-5-4
View Evidence →